Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-08-20
2000-05-09
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514256, 514339, 514413, 5462767, 5483121, 548452, 548466, 544333, 544405, C07D41304, C07D41704, C07D40104, A61K 3144
Patent
active
060604735
ABSTRACT:
7-Azabicyclo[2.2.1]-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.
REFERENCES:
patent: 4835162 (1989-05-01), Abood
patent: 4910193 (1990-03-01), Buchheit
patent: 4940703 (1990-07-01), Baker et al.
patent: 4966916 (1990-10-01), Abood
patent: 4992436 (1991-02-01), Baker et al.
patent: 5104989 (1992-04-01), Cottrell et al.
patent: 5106853 (1992-04-01), Showell et al.
patent: 5124460 (1992-06-01), Humphrey
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5219860 (1993-06-01), Chambers et al.
patent: 5227385 (1993-07-01), Caldwell et al.
patent: 5242927 (1993-09-01), Baker et al.
patent: 5242930 (1993-09-01), Baker et al.
patent: 5256671 (1993-10-01), Ladduwahetty
patent: 5260293 (1993-11-01), Baker et al.
patent: 5288730 (1994-02-01), Baker et al.
patent: 5314899 (1994-05-01), Daly et al.
patent: 5324723 (1994-06-01), Baker et al.
patent: 5405853 (1995-04-01), Baker et al.
patent: 5426106 (1995-06-01), Kalagowski et al.
patent: 5432177 (1995-07-01), Baker et al.
patent: 5444074 (1995-08-01), Baker et al.
patent: 5451588 (1995-09-01), Baker et al.
patent: 5459270 (1995-10-01), Williams et al.
patent: 5461063 (1995-10-01), Kelleher et al.
Abstracts of Poster Presentations Nos. 1-97, "The Otto Loewi New Investigator Awards for 1995," Life Sciences, 56(11/12):1001-1050 (1995).
Adamus, et al., "Phase I Clinical Trials with WAL2014, A New Muscarinic Agonist for the Treatment of Alzheimer's Disease," Life Sciences, 56:(11/12):883-890 (1995) (Elsevier Sciences, Ltd., Editors).
Ainsworth, et al., "Alkyl-1,3,4-oxadiazoles," J. Org. Chem., 31:3442-3444 (1966).
Altenbach, H.J., et al., "7-Azanorbornadiene," Angew Chem. Int. Ed. Engl., 21(10):778 (1992).
Altenbach, H.J., et al., "Syntheses and Photoelectron Spectra of 7-Azanorbornadiene and Related Compounds. An Analysis with Fragment Orbitals," Chem. Ber. 124:791-801 (1991).
Badio and Daly, "Epibatidine, a Potent Analgetic and Nicotinic Agonist," Mol. Pharmacol., 45:563-569 (1994).
Badio and Daly, "Epibatidine. A potent analgetic and nicotinic agonist," FASEB Journal, 8(4-5):A875 (1994).
Baker and Saunders, "Central Muscarinic Ligands and Receptors," Ann. Rep. in Med. Chem. Chapter 4, 24:31-39 (1989).
Bansal, et al., "Influence of Lewis acids on the Diels-Alder reaction. Part I. An improved synthesis of 7-azanorbornadiene, 3-azaquadricyclaine, and azepine derivatives," Can. J. Chem., 47:2391-2394 (1969).
Barber, and Gottschlich, "Opioid Agonists and Antagonists: An Evaluation of Their Peripheral Actions in Inflammation," Medicinal Research Review, 12(5):525-562 (1992).
Barnes, et al., "Tiotropium Bromide (Ba 679 BR), a Novel, Long-Acting Muscarinic Antagonist for the Treatment of Obstructive Airways Disease," Life Sciences, 56:(11/12):853-859 (1995) (Elsevier Science, Ltd., Editors).
Bhattacharya, S.N., et al., "Friedel-Crafts Sulphonylation of Bis(trimethylsilyl)acetylene: a Useful Route to Aryl Ethynyl Sulphones," Organomet. Chem. Synth., 1:145-149 (1970).
Bittoun, "Recurrent aphthous ulcers and nicotine," Med. J. Australia, 154:471-472 (1991).
Bradley, "Frog Venom Cocktail Yields A One-Handed Painkiller," Science 261:1117 (1993).
Broka, C.A., "Total Synthesis of Epibatidine," Tet. Lett., 34(20):3251-3254 (1993).
Burgen, "The Background of the Muscarinic System," Life Sciences, 56(11/12):801-806 (1995) (Elsevier Science, Ltd., Editors).
Burke, et al., "Construction of a Molecular Shape Analysis-Three-Dimensional Quantitative Stucture-Analysis Relationship for an Analog Series of Pyridobenzodiazepinone Inhibitors of Muscarinic 2 and 3 Receptors," J. Med. Chem., 37:3775-3788 (1994).
Carroll, et al., "3-Aryl-2-(3'-substituted-1',2',4'-oxiadiazol-5'-yl)tropane Analogues of Cocaine: Affinities at the Cocaine Binding Site at the Dopamine, Serotonin, and Norepinephrine Transporters," J. Med. Chem., 36:2886-2890 (1993).
Clayton and Regan, "A Total Synthesis of (+/-) Epibatidine," Tetrahedron Letters, 34(46):7493-7496 (1993).
Cooley, et al., "Effect of pCPA on Nicotine-Induced Analgesia," Pharmacol. Biochem. Behav., 36:413-415 (1990).
Cordone, R., et al., ".pi.-Heterocyclic Complexes of Pentaammineosmium(II) and the Metal-Induced Cycloaddition of Pyrrole and Maleic Anhydride," J. Am. Chem. Soc., 111:5969-5970 (1989).
Corey, E.J., et al., "Stereocontrolled Total Synthesis of (+)- and (-)-epibatidine," J. Org. Chem., 58:(21):5600-5602 (1983).
Corey, et al., "A Synthetic Method for Formyl-Ethynyl Conversion (RCHO->RC=CH or RC=CR')," Tetrahedron Letters, 36:3769-3772 (1972).
Daly, et al., "A New Class of Indolizidine Alkaloids from Poison Frog, Dendrobates tricolor. X-ray Analysis of 8-Hydroxy-8-methyl-6-(2'-methylhexylidene)-1-azabicyclo[4.3.0]nonane," J. Am. Chem. Soc., 102:830-836 (1980).
Davis and Whitham, "Ethynyl p -Tolyl Sulphone as an Acetylene Equivalent in Diels-Alder Reactions," J.C.S. Chem. Comm., pp. 639 (1980).
Devor and Isenberg, "Nicotine and Tourette's Syndrome," Lancet, 2:1046 (1989).
Donnini and Just, "Diels-Alder Reactions of Pyrroles as an Entry to Substituted 3-Oxatropanes and Tetrasubstituted Pyrrolidines," Heterocycl. Chem., 14:1423-1425 (1977).
Drew, et al., "High-pressure Synthesis, Structures, and Conformational Properties of Some Derivatives of 7-Azabicyclo[2.2.1]heptane. X-Ray Determiniation of endo -10-Benzoyl-4-phenyl-4,10-diazatricyclo[5.2.1.0.sup.2,6 ]dec-8-ene-3,5-dione and exo -10-Acetl-4-phenyl-4,10-diazatricyclo[5.2.1.0.sup.2,6 ]decane-3,5-dione," J.C.S. Perkins Trans I:1277-1284 (1985).
Dukat, M.; et al., "Epibatidine: A very high affinity nicotine-receptor ligand," Medicinal Chem. Res., 4:131-139 (1994).
Duvoisin, "Cholinergic-Anticholinergic Antagonism in Parkinsonism," Arch. Neurol. 17:124-136 (1967).
Ehlert and Thomas, "Functional Role of M.sub.2 Muscarinic Receptors in the Guinea Pig Ileum," Life Sciences, 56(11/12):965-971 (1995) (Elsevier Science, Ltd., Editors).
Ehringer and Hornykiewicz, "Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems," Klin. Wochenschr., 38:1236-1239 (1960).
Feriani, et al., "Cholinergic Agents Structurally Related to Furtrethonium. 2. Synthesis and Antimuscarinic Activity of a Series of N-[5-[(1'-Substituted-acetoxy)methyl]-2-furfuryl]dialkylamines," J. Med. Chem., 37:4278-4287 (1994).
Fisher, et al., "Epibatidine, An Alkaloid From the Poison Frog Epipedobates tricolor, Is a Powerful Ganglionic Depolarizing Agent," J. of Pharm. and Exp. Therap. 270:702-707 (1994).
Fitjer, et al., "The Wittig Reaction using Potassium-Tert-Butoxide High Yield Methylenations of Sterically Hindered Ketones," Synthetic Communications, 15(10):855-864 (1985).
Fletcher, et al., "The Synthesis of (+) and (-) Epibatidine," J. Chem. Soc. Chem. Comm., 1216-1218 (1993).
Fletcher, S., et al., "Total synthesis and determination of the absolute configuration of epibatidine," J. Org. Chem., 59(7):1771-1778 (1994).
Flynn, et al., "Differential Alterations in Mscarinic Receptor Subtypes in Alzheimer's Disease: Implications for Cholinergic-Based Therapies," Life Sciences, 56(11/12):868-876 (1995) (Elsivier Science, Ltd., Editors).
Fraser and Lee, "Regulation of Muscarinic Receptor Expression of Changes in mRNA Stability," Life Science, 56(11/12):899-906 (1995) (Elsevier Sciences, Ltd., Editors).
Fraser, et al., "Synthesis of 7-azabicyclo[2.2.1]heptane, exo -2-chloro-7-azabicyclo[2.2.1]heptane, and derivatives," Can. J. Chem., 48:2065-2074 (1970).
Gabel, N.W., "Diels-Alder Reactions of 1-Carbomethoxy-pyrroles and Dimethyl cetylenedicarboxylate," J. Org. Chem., 27:301-303 (1962).
Garvey, et al., "Novel Isoxazoles which Interact with Brain Cholinergic Channel Receptors Have Intrinsic Cognitive Enhancing and Anxiolytic Activities," J. Med. Chem., 37:1055-1059 (1994).
Garvey, et al., "Synthesis and in Vitro Characterization of Novel Amino Terminally Modified Oxotremorine Derivaties for Brain Muscarinic Receptors," J. Med. Chem., 35:1550-1557 (1992).
Glassman and Covey, "Future Trends in
Gonzalez Javier
Harman W. Dean
Huang Dao Fei
Shen T. Y.
Rotman Alan L.
UCB S.A. - DTB
LandOfFree
7-azabicyclo[2.2.1]-heptane and -heptene derivatives as choliner does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as choliner, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as choliner will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065325